AstraZeneca Covid-19 vaccine trial resumes after pausing over safety concerns

Clinical trials for the AstraZeneca Covid-19 vaccine have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so.

The company paused trials earlier this week after a possible adverse severe reaction in one participant.

In a statement, the company said it "will continue to work with health authorities across the world and be guided as to when other clinical trials can resume to provide the vaccine broadly, equitably and at no profit during this pandemic."

Co-founder of Pendect, passionate about open source and knowledge sharing. Made in Mooca.
Card reviewed by: @christoph